企業プロフィール
Codexis 株価・ニュース・カタリスト
- ティッカー:
- CDXS
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
1.66 USD (-0.60%)
終値
最終更新: 2026年8月24日
245M USD
時価総額
株価変動の要因
As of Aug 24, 2026, CDXS closed down 0.60% at $1.66. No new same-company headline was identified in the current news window.
企業概要
事業概要
Codexis is an enzyme-engineering company that serves pharma manufacturing, therapeutics, and bioprocessing needs. Its business is built around using protein engineering to solve industrial and healthcare problems.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Codexis sits in life-sciences tools and biotech infrastructure.
ビジネスモデルの特徴
The company depends on platform adoption, customer relationships, and the monetization of engineered enzymes across markets.
バイオ業界での位置付け
Codexis is a biotech-enabling platform name rather than a drug developer.
今後のカタリスト
- Codexis’s catalysts are enzyme-engineering partnerships, next-gen biocatalyst demand, and any update that shows the platform is still winning in pharma manufacturing and sequencing workflows. Investors will care about whether recurring platform revenue keeps proving the model works.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。